Report Overview
Report Summary
The global Etoposide market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Etoposide market based on company, product type, end user and key regions.
This report studies the global market size of Etoposide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Etoposide in these regions.
This research report categorizes the global Etoposide market by top players/brands, region, type and end user. This report also studies the global Etoposide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shyndec Pharmaceutical
Qilu Antibiotics
Gansu Fuzheng
KPC Pharmaceuticals
China Resources Double Crane Pharmaceutical
Nippon Kayaku
Accord Healthcare
Teva Pharmaceutical
Mylan
Market size by Product
Etoposide for Injection
Etoposide for Oral Use
Market size by End User
Small Cell Lung Cancer
Testicular Cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Etoposide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Etoposide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Etoposide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Etoposide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Etoposide are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Etoposide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Etoposide Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Etoposide Market Size Growth Rate by Product
1.4.2 Etoposide for Injection
1.4.3 Etoposide for Oral Use
1.5 Market by End User
1.5.1 Global Etoposide Market Size Growth Rate by End User
1.5.2 Small Cell Lung Cancer
1.5.3 Testicular Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Etoposide Market Size
2.1.1 Global Etoposide Revenue 2017-2027
2.1.2 Global Etoposide Sales 2017-2027
2.2 Etoposide Growth Rate by Regions
2.2.1 Global Etoposide Sales by Regions
2.2.2 Global Etoposide Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Etoposide Sales by Manufacturers
3.1.1 Etoposide Sales by Manufacturers
3.1.2 Etoposide Sales Market Share by Manufacturers
3.1.3 Global Etoposide Market Concentration Ratio (CR5 and HHI)
3.2 Etoposide Revenue by Manufacturers
3.2.1 Etoposide Revenue by Manufacturers (2017-2020)
3.2.2 Etoposide Revenue Share by Manufacturers (2017-2020)
3.3 Etoposide Price by Manufacturers
3.4 Etoposide Manufacturing Base Distribution, Product Types
3.4.1 Etoposide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Etoposide Product Type
3.4.3 Date of International Manufacturers Enter into Etoposide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Etoposide Sales by Product
4.2 Global Etoposide Revenue by Product
4.3 Etoposide Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Etoposide Breakdown Data by End User
6 North America
6.1 North America Etoposide by Countries
6.1.1 North America Etoposide Sales by Countries
6.1.2 North America Etoposide Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Etoposide by Product
6.3 North America Etoposide by End User
7 Europe
7.1 Europe Etoposide by Countries
7.1.1 Europe Etoposide Sales by Countries
7.1.2 Europe Etoposide Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Etoposide by Product
7.3 Europe Etoposide by End User
8 Asia Pacific
8.1 Asia Pacific Etoposide by Countries
8.1.1 Asia Pacific Etoposide Sales by Countries
8.1.2 Asia Pacific Etoposide Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Etoposide by Product
8.3 Asia Pacific Etoposide by End User
9 Central & South America
9.1 Central & South America Etoposide by Countries
9.1.1 Central & South America Etoposide Sales by Countries
9.1.2 Central & South America Etoposide Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Etoposide by Product
9.3 Central & South America Etoposide by End User
10 Middle East and Africa
10.1 Middle East and Africa Etoposide by Countries
10.1.1 Middle East and Africa Etoposide Sales by Countries
10.1.2 Middle East and Africa Etoposide Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Etoposide by Product
10.3 Middle East and Africa Etoposide by End User
11 Company Profiles
11.1 Shyndec Pharmaceutical
11.1.1 Shyndec Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 Shyndec Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Shyndec Pharmaceutical Etoposide Products Offered
11.1.5 Shyndec Pharmaceutical Recent Development
11.2 Qilu Antibiotics
11.2.1 Qilu Antibiotics Company Details
11.2.2 Company Business Overview
11.2.3 Qilu Antibiotics Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Qilu Antibiotics Etoposide Products Offered
11.2.5 Qilu Antibiotics Recent Development
11.3 Gansu Fuzheng
11.3.1 Gansu Fuzheng Company Details
11.3.2 Company Business Overview
11.3.3 Gansu Fuzheng Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Gansu Fuzheng Etoposide Products Offered
11.3.5 Gansu Fuzheng Recent Development
11.4 KPC Pharmaceuticals
11.4.1 KPC Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 KPC Pharmaceuticals Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.4.4 KPC Pharmaceuticals Etoposide Products Offered
11.4.5 KPC Pharmaceuticals Recent Development
11.5 China Resources Double Crane Pharmaceutical
11.5.1 China Resources Double Crane Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 China Resources Double Crane Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.5.4 China Resources Double Crane Pharmaceutical Etoposide Products Offered
11.5.5 China Resources Double Crane Pharmaceutical Recent Development
11.6 Nippon Kayaku
11.6.1 Nippon Kayaku Company Details
11.6.2 Company Business Overview
11.6.3 Nippon Kayaku Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Nippon Kayaku Etoposide Products Offered
11.6.5 Nippon Kayaku Recent Development
11.7 Accord Healthcare
11.7.1 Accord Healthcare Company Details
11.7.2 Company Business Overview
11.7.3 Accord Healthcare Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Accord Healthcare Etoposide Products Offered
11.7.5 Accord Healthcare Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Teva Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Teva Pharmaceutical Etoposide Products Offered
11.8.5 Teva Pharmaceutical Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Company Business Overview
11.9.3 Mylan Etoposide Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Mylan Etoposide Products Offered
11.9.5 Mylan Recent Development
12 Future Forecast
12.1 Etoposide Market Forecast by Regions
12.1.1 Global Etoposide Sales Forecast by Regions 2021-2027
12.1.2 Global Etoposide Revenue Forecast by Regions 2021-2027
12.2 Etoposide Market Forecast by Product
12.2.1 Global Etoposide Sales Forecast by Product 2021-2027
12.2.2 Global Etoposide Revenue Forecast by Product 2021-2027
12.3 Etoposide Market Forecast by End User
12.4 North America Etoposide Forecast
12.5 Europe Etoposide Forecast
12.6 Asia Pacific Etoposide Forecast
12.7 Central & South America Etoposide Forecast
12.8 Middle East and Africa Etoposide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Etoposide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer